Call: 470-589-5858
Spravato (esketamine) is FDA-approved for treatment-resistant depression — and works when other medications haven't.
Check If You Qualify →Treatment-resistant depression is real. If you've been through this cycle, you're not alone:
Spravato works differently — targeting glutamate receptors rather than serotonin, which is why it helps when SSRIs fail.
We review your history and confirm if Spravato is right for you.
We verify your coverage — most major insurers cover Spravato.
Self-administer the nasal spray and relax in our office for 2 hours.
Many patients notice improvement within the first 1–2 weeks.
Many patients feel improvement within hours to days — not weeks like traditional antidepressants.
Targets glutamate receptors, not serotonin — a completely different pathway that helps when SSRIs fail.
Approved in 2019 for treatment-resistant depression, and in 2020 for MDD with suicidal ideation.
Sessions twice a week, then less frequently — no medication to remember daily.
Medicare, Medicaid, and most private insurers cover Spravato with prior authorization.
Every session monitored by our board-certified psychiatric team in a safe, comfortable setting.
You've tried 2+ antidepressants without adequate relief
You have a diagnosis of Major Depressive Disorder
You experience persistent depression despite treatment
You have active suicidal ideation with a depressive episode
You can come in for supervised in-office sessions
You have a driver or rideshare after each session
Hear from patients who found relief with Spravato — even after years of trying other treatments.
"I'd tried 4 antidepressants over 6 years. After my third Spravato session I felt something shift. I finally feel like myself again — present, clear-headed, and actually hopeful."
"Dr. Matzkin explained everything clearly and I never felt rushed. The process was comfortable, and the results have been life-changing. I wish someone had told me about this years ago."
"My insurance covered most of it after the team handled the prior authorization. I was skeptical but desperate. Spravato gave me my life back when I had almost given up."
"I have active suicidal ideation — Spravato was specifically approved for that. Within two sessions the darkness lifted noticeably. The monitored setting actually made me feel safe."
"I was nervous about a nasal spray for depression — it sounded too unconventional. But the staff made every session calming and professional. Eight months out and still feeling the difference."
Ready to start your own story?
Check If You Qualify — FreeMost major insurance plans accepted · No referral needed
Yes — Medicare, Medicaid, and most private plans cover Spravato with prior authorization. Our team handles the process for you.
About 2 hours total. You self-administer the nasal spray, then rest while staff monitors you. You'll need a driver home after.
Many patients notice improvement within the first 1–4 sessions — much faster than traditional antidepressants.
Spravato (esketamine) is derived from ketamine but is FDA-approved specifically for depression and given as a nasal spray in a medical setting.
Decatur, GA — serving Atlanta and surrounding communities. Call 470-589-5858 to schedule.
We'll check your eligibility and insurance coverage at no cost to you.
Get a Free Consultation →